#Billion #Diabetic #Retinopathy #Market #Size #Grow
New York, Oct. 19, 2022 (GLOBE NEWSWIRE) — According to The Insight Partners latest market study on “Diabetic Retinopathy Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Treatment, Distribution Channel, Application, and Geography,” the global diabetic retinopathy market size is expected to grow from USD 7.78 billion in 2021 to USD 12.04 billion by 2028; it is expected to grow at a CAGR of 6.5% from 2022 to 2028.
Download Sample PDF Brochure of Diabetic Retinopathy Market Size – COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00004185/
Global Diabetic Retinopathy Market Report Scope, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 7.78 Billion in 2021 |
| Market Size Value by | USD 12.04 Billion by 2028 |
| Growth rate | CAGR of 6.5% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
| No. of Pages | 150 |
| Historical data available | Yes |
| Segments covered | Type, Treatment, and Distribution Channel |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Global Diabetic Retinopathy Market: Competitive Landscape
Abbott Laboratories, Alimera Science, Allergan Plc, Ampio Pharmaceuticals, Bayer AG, F. Hoffmann-LA Roche, Novartis International AG, PFIZER, Regeneron Pharmaceuticals Inc, and Valeant Pharmaceutical are a few of the key market players profiled during the study. Several other major companies were analyzed during this study to get a holistic view of the global diabetic retinopathy market.
Impact of COVID-19 Pandemic on Global Diabetic Retinopathy Market:
The COVID-19 pandemic adversely impacted the global diabetic retinopathy market. It led to…
Read on GNW: $12+ Billion Diabetic Retinopathy Market Size to Grow at a
